Grady Grant III

CIK: 0001679966

Transaction Breakdown

Open Market Buys (P)1 (25.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (50.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

APVO

Aptevo Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

APVO
Aptevo Therapeutics Inc.
Aug 6, 2026
Exercise(M)
Direct
400 shares-
APVO
Aptevo Therapeutics Inc.
Nov 10, 2025
Purchase(P)
Direct
13.5K shares at avg. $1.49$20K
APVO
Aptevo Therapeutics Inc.
Aug 6, 2025
Award(A)
Restricted Stock Unit
Direct
7.2K shares-
APVO
Aptevo Therapeutics Inc.
Jul 17, 2025
Exercise(M)
Direct
1 shares-

		Type	Shares	Price		Ownership
Aug 6, 2026	APVO Aptevo Therapeutics Inc.	Exercise(M)	400	-	$0	Direct
Nov 10, 2025	APVO Aptevo Therapeutics Inc.	Purchase(P)	13,513	$1.49	$20,134	Direct
Aug 6, 2025	APVO Aptevo Therapeutics Inc.	Award(A) Restricted Stock Unit	7,200	-	-	Direct
Jul 17, 2025	APVO Aptevo Therapeutics Inc.	Exercise(M)	1	-	-	Direct

1-4 of 4 transactions

About Grant Grady III

Grant Grady III (SEC CIK 0001679966) files insider reports with the SEC as Director of Aptevo Therapeutics Inc. (APVO).

Signal8 holds 4 ownership filings by Grant Grady III, all Form 4s, filed between Jul 21, 2025 and Aug 10, 2026. Those filings report 4 transactions, from Jul 17, 2025 to Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Grant Grady III's filings is in SEATTLE, WA.

Recent filings by Grant Grady III

Aug 6, 2026: Option exercise of APVO shares (Form 4, code M).
Nov 10, 2025: Open-market purchase of APVO shares (Form 4, code P).
Aug 6, 2025: Grant or award of APVO derivative securities (Form 4, code A).
Jul 17, 2025: Option exercise of APVO shares (Form 4, code M).

Other insiders filing for Aptevo Therapeutics Inc. (APVO)

Harsanyi Zsolt, Director
Lamothe Jeffrey G., President and CEO
Taylor Daphne, SVP, CFO
Kwon SoYoung, SVP, GC, BD & Corp Affairs
Huebner Dirk, SVP, CMO
White Marvin L, Executive Chair

How to read Form 4 transaction codes